Skip to main content
Premium Trial:

Request an Annual Quote

Integromics, CEIT, CITRE Partner on Data Analysis Methods for Clinical Genomics

NEW YORK (GenomeWeb News) – Integromics today announced a partnership with two Spanish organizations to develop new data analysis methods for clinical genomic studies.

In support of the work, Spain's government has awarded the partners €2 million ($2.6 million) to develop algorithms and statistical tools for identifying alternative splicing events that are associated with disease biomarkers or identifying therapeutic targets using RNA sequencing.

Together with the Celgene Institute for Translational Research Europe, or CITRE, and the Centre of Studies and Technical Research, or CEIT, Integromics will conduct a project called Sanscript that seeks to tackle current limitations in algorithms for the characterization of gene alterations.

Integromics said that because of the present limitations, "it is essential to adapt the present methods … for the new massive sequencing technologies to extract all their potential for [the] development of diagnostic and prognostic tests, and drug discovery in the clinical and pharmaceutical environment."

Sanscript-developed solutions will be validated for use in developing drugs for personalized medicine. In such processes, "gene expression is essential to [understanding] the differing responses to treatment," the company added.

Integromics Chief Strategy Officer Eduardo González Couto said in a statement that the grant provides "key financial support" for Sanscript's efforts in spearheading the use of next-generation sequencing in drug develop.

With improvements in NGS platform technologies, generating NGS data is no longer an issue, but making sense of the data is, he added.

"In order to identify the gene expression changes associated [with] sensitivity to treatment, including the detailed characterization of transcription isoforms for clinical usage, bioinformatics tools are crucially needed to design novel algorithms from the very beginning to be compatible with long reads from upcoming NGS technologies," Couto said.

Integromics, with offices in Madrid and Granada, Spain, as well as Madison, Wis., develops and markets data analysis solutions for the life sciences. CITRE, headquartered in Seville, Spain, is a wholly owned subsidiary of biopharmaceutical company Celgene. CEIT, based in San Sebastián, Spain, collaborates with industry on applied industrial research projects.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.